Logo
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Ελληνικά 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Σύνδεση
Πλοήγηση ανά Θέμα 
  •   Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
  • Πλοήγηση ανά Θέμα
  •   Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
  • Πλοήγηση ανά Θέμα
JavaScript is disabled for your browser. Some features of this site may not work without it.
Ιδρυματικό Αποθετήριο Πανεπιστημίου Θεσσαλίας
Όλο το DSpace
  • Κοινότητες & Συλλογές
  • Ανά ημερομηνία δημοσίευσης
  • Συγγραφείς
  • Τίτλοι
  • Λέξεις κλειδιά

Πλοήγηση ανά Θέμα "DOWN-REGULATION"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Α
  • Β
  • Γ
  • Δ
  • Ε
  • Ζ
  • Η
  • Θ
  • Ι
  • Κ
  • Λ
  • Μ
  • Ν
  • Ξ
  • Ο
  • Π
  • Ρ
  • Σ
  • Τ
  • Υ
  • Φ
  • Χ
  • Ψ
  • Ω

Ταξινόμηση κατά:

Σειρά:

Αποτελέσματα:

Αποτελέσματα 1-9 από 9

  • τίτλος
  • ημερομηνία δημοσίευσης
  • ημερομηνία υποβολής
  • αύξουσα
  • φθίνουσα
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Thumbnail

      Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner 

      Vlachostergios, P. J.; Hatzidaki, E.; Befani, C. D.; Liakos, P.; Papandreou, C. N. (2013)
      Development of drug resistance after standard chemotherapy for glioblastoma multiforme (GBM) with temozolomide (TMZ) is associated with poor prognosis of GBM patients and is at least partially mediated by a direct DNA ...
    • Thumbnail

      Bortezomib represses HIF-1 alpha protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells 

      Befani, C. D.; Vlachostergios, P. J.; Hatzidaki, E.; Patrikidou, A.; Bonanou, S.; Simos, G.; Papandreou, C. N.; Liakos, P. (2012)
      Bortezomib represents the first proteasome inhibitor (PI) with demonstrated antitumor activity in the clinical setting, particularly for treatment of hematological malignancies. At the preclinical level, its action is shown ...
    • Thumbnail

      HIF-1a in colorectal carcinoma: review of the literature 

      Ioannou, M.; Paraskeva, E.; Baxevanidou, K.; Simos, G.; Papamichali, R.; Papacharalambous, C.; Samara, M.; Koukoulis, G. (2015)
      Colorectal cancer (CRC) is the third most common cancer worldwide and despite the abundance of molecular pathways and markers continually being reported, the mortality rates remain high. Hypoxia inducible factor 1alpha ...
    • Thumbnail

      Increased Plasma Angiogenin Level is Associated and May Contribute to Decreased T-Cell Zeta-Chain Expression in Hemodialysis Patients 

      Eleftheriadis, T.; Kartsios, C.; Pissas, G.; Liakopoulos, V.; Antoniadi, G.; Galaktidou, G.; Stefanidis, I. (2013)
      Hemodialysis (HD) patients are characterized by impaired T-cell function at least in part because of T-cell zeta-chain downregulation due to inflammation. Angiogenin responds as an acute phase reactant, is increased in HD ...
    • Thumbnail

      Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections 

      Eleftheriadis, T.; Liakopoulos, V.; Leivaditis, K.; Antoniadi, G.; Stefanidis, I. (2011)
      Hemodialysis (HD) patients are particularly predisposed to infections. It seems that the HD procedure per se as well as disturbances in both innate and adaptive immunity significantly contribute to this susceptibility. ...
    • Thumbnail

      Inverse Association of Serum 25-Hydroxyvitamin D With Markers of Inflammation and Suppression of Osteoclastic Activity in Hemodialysis Patients 

      Eleftheriadis, T.; Antoniadi, G.; Liakopoulos, V.; Stefanidis, I.; Galaktidou, G. (2012)
      Introduction. In hemodialysis patients, 25-hydroxyvitamin D conversion to active 1,25-dihydroxyvitamin D by the kidneys is very limited. The expression of both vitamin D receptor and 1 alpha-hydroxylase in cells of the ...
    • Thumbnail

      The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells 

      Papanikolaou, V.; Iliopoulos, D.; Dimou, I.; Dubos, S.; Tsougos, I.; Theodorou, K.; Kitsiou-Tzeli, S.; Tsezou, A. (2009)
      Cancer cell characteristics may play a pivotal role in the response to therapy by activating or deactivating different molecular pathways. In the present study, we investigated the implication of breast cancer cell features, ...
    • Thumbnail

      Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts 

      Psahoulia, F. H.; Drosopoulos, K. G.; Doubravska, L.; Andera, L.; Pintzas, A. (2007)
      Cytokines such as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can induce apoptosis in colon cancer cells through engagement of death receptors. Nevertheless, evading apoptosis induced by anticancer drugs ...
    • Thumbnail

      The ubiquitin-proteasome system in glioma cell cycle control 

      Vlachostergios, P. J.; Voutsadakis, I. A.; Papandreou, C. N. (2012)
      A major determinant of cell fate is regulation of cell cycle. Tight regulation of this process is lost during the course of development and progression of various tumors. The ubiquitin-proteasome system (UPS) constitutes ...
      Η δικτυακή πύλη της Ευρωπαϊκής Ένωσης
      Ψηφιακή Ελλάδα
      ΕΣΠΑ 2007-2013
      Με τη συγχρηματοδότηση της Ελλάδας και της Ευρωπαϊκής Ένωσης
      htmlmap 

       

      Πλοήγηση

      Όλο το DSpaceΚοινότητες & ΣυλλογέςΑνά ημερομηνία δημοσίευσηςΣυγγραφείςΤίτλοιΛέξεις κλειδιά

      Ο λογαριασμός μου

      ΣύνδεσηΕγγραφή (MyDSpace)
      Πληροφορίες-Επικοινωνία
      ΑπόθεσηΣχετικά μεΒοήθειαΕπικοινωνήστε μαζί μας
      Επιλογή ΓλώσσαςΌλο το DSpace
      EnglishΕλληνικά
      Η δικτυακή πύλη της Ευρωπαϊκής Ένωσης
      Ψηφιακή Ελλάδα
      ΕΣΠΑ 2007-2013
      Με τη συγχρηματοδότηση της Ελλάδας και της Ευρωπαϊκής Ένωσης
      htmlmap